Similarly, treatment with the GLUT5 inhibitor, 2,5-AM, suppressed fructose-induced cell growth while stimulating apoptosis in ccRCC cells (Jin et al. 2019) (Fig. 3). The gene discussed is SLC2A5; the disease is nonpapillary renal cell carcinoma.